slides · global inventory
02 Pattern Hunter
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 5,253
Current window 4,651-4,680
Pages 176
Rows per page 30
Loop
4,651-4,680 of 5,253
06
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
07
The slide uses donut charts to show revenue composition and lists reported vs organic growth rates for each segment.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
08
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
09
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
10
Includes revenue figures in millions USD and percentage growth metrics.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide uses a 2x2 grid layout to segment performance data by business unit.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
The slide uses a combination of bar charts for total revenue and donut charts for segment composition, followed by a detailed list of key drivers.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
The table includes both GAAP and non-GAAP (organic) measures, with a footnote referencing the appendix for further details.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
Includes GAAP metrics for revenue, profit, operating expenses, income, net income, EPS, and cash flow.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
Includes footnotes referencing slides 44 and 45.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The chart uses a bridge format to reconcile Q3 2022 costs to Q3 2023 costs.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
The chart includes a secondary metric in bps of average loans annualized.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
Includes waterfall charts for ratio movements and a stacked bar chart for MREL/TLAC composition.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
Deutsche Bank Q3 2023 results presentation slide.Deutsche Bank | Results Presentation Deck | 47 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide uses a consistent color palette to distinguish business segments and financial metrics across three distinct bar charts.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
12
The slide uses a series of bar charts to display performance trends over five quarters (3Q22 to 3Q23).Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
13
Lazard | Investor Presentation Deck | 46 slidesLazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
14
The slide uses a 4x3 grid of metrics to summarize the business scale and composition.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
15
Data as of September 30, 2023.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
16
The slide uses a combination of bar charts and line overlays to show performance metrics from 2016 to 3Q23/LTM.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · FinancialsLoop · Pattern Hunter1 hit
09
This slide serves as a transition or key message reinforcement.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
10
The slide uses a visual comparison between telomere targeting (left) and PD-1/PD-L1 checkpoint inhibition (right).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
11
Slide highlights a strategic partnership/supply agreement as a form of business traction.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
12
The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
13
The slide outlines a clinical trial process flow including randomization and expansion phases.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
08
The table highlights clinical status, mechanism of action, efficacy, safety, and strategic differentiation.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
11
Includes footnotes detailing stock-based compensation components.Nikola | Results Presentation Deck | 19 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
Nikola | Results Presentation Deck | 19 slidesNikola | Results Presentation Deck | 19 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
Includes footnotes regarding order conditions and currency units.Nikola | Results Presentation Deck | 19 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit